edoxaban
Facts
15 properties- Instance of
- type of chemical entity
- Has use
- medication
- Active ingredient in
- Savaysa
- Canonical SMILES
- CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C
- Chemical formula
- C₂₄H₃₀ClN₇O₄S
- Defined daily dose
- 60 mg
- Isomeric SMILES
- CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3C[C@H](CC[C@@H]3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C
- LiverTox likelihood score
- LiverTox toxicity likelihood category E*
- Mass
- 547.176851 Da
- Medical condition treated
- pulmonary embolism, atrial fibrillation, pulmonary embolism (2015–present)
- Physically interacts with
- coagulation factor X
- Pregnancy category
- US pregnancy category C
- Subject has role
- direct Xa inhibitor
- World Health Organisation international non-proprietary name
- edoxaban, édoxaban, edoxabán, эдоксабан, إيدوكسابان, 艾多沙班
- GND ID
- 1366430328
- OpenAlex ID
- C2780290652
- ATC code
- B01AF03
- CAS Registry Number
- 480449-70-5
- ChEBI ID
- 85973
- ChEMBL ID
- CHEMBL1269025
- ChemSpider ID
- 8456212
- DSSTOX compound identifier
- DTXCID60119889
- DSSTox substance ID
- DTXSID50197398
- DrugBank ID
- DB09075
- DrugCentral ID
- 4897
- Electronic Essential Medicines List medicine ID
- 480
Show all 34 identifiers +22
- Freebase ID
- /m/0dgqwyh
- Guide to Pharmacology Ligand ID
- 7575
- HSDB ID
- 8406
- InChIKey
- HGVDHZBSSITLCT-JLJPHGGASA-N
- KEGG ID
- D09710
- LiverTox ID
- Edoxaban
- MeSH descriptor ID
- C552171
- MedlinePlus drug identifier
- a614055
- Microsoft Academic ID (discontinued)
- 2780290652
- NDF-RT ID
- N0000191384
- PatientsLikeMe treatment ID
- edoxaban
- Probes And Drugs ID
- PD009142
- PubChem CID
- 10280735
- Reaxys registry number
- 11407476
- RxNorm CUI
- 1599538
- SureChEMBL ID
- 330046
- UMLS CUI
- C2975435
- UNII
- NDU3J18APO
- UniChem compound ID
- 791627
- WikiProjectMed ID
- Edoxaban
- World Health Organisation international non-proprietary name numeric ID
- 8982
Medical condition treated 3
← Drug or therapy used for treatment 3
Physically interacts with 2
← Physically interacts with 2
Has use 1
Subject has role 1
0 sources
Summary
edoxaban is a type of chemical entity[1]. edoxaban is a type of N1-(5-Chloropyridin-2-yl)-N2-((1R,2S,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide[2].
Key Facts
- Physically interacts with: coagulation factor X[3]
- Canonical SMILES: CN1CCC2=C(C1)SC(=N2)C(=O)NC3CC(CCC3NC(=O)C(=O)NC4=NC=C(C=C4)Cl)C(=O)N(C)C[4]
- Chemical formula: C₂₄H₃₀ClN₇O₄S[5]
- Has use: medication[6]
- Isomeric SMILES: CN1CCC2=C(C1)SC(=N2)C(=O)N[C@@H]3CC@HC(=O)N(C)CC@HC(=O)N(C)C">[7]
- Mass: 547.176851 dalton[8]
- Medical condition treated: pulmonary embolism[9], atrial fibrillation[10]
- World Health Organisation international non-proprietary name: edoxaban[11], édoxaban[12], edoxabán[13], эдоксабан[14], إيدوكسابان[15], 艾多沙班[16]
- Subject has role: direct Xa inhibitor[17]
- Pregnancy category: US pregnancy category C[18]
- Active ingredient in: Savaysa[19]
- Defined daily dose: 60 milligram[20]
- LiverTox likelihood score: LiverTox toxicity likelihood category E*[21]